SHPH

Shuttle Pharmaceuticals Holdings, Inc.

$5.34

2.89%

SectorHealthcareIndustryDrug Manufacturers - Specialty & GenericCountryUnited States

Overview AI Brief ChartChart & Performance Financials ExposureRevenue Exposure FilingsFilings & Red Flags ScoresScores & Valuation News Analysts InsidersInsiders & Short Interest Ownership

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Source: Yahoo Finance

Market Cap$25.4M

Dividend Yield0.00%

Beta0.32

AI summary

Price & performance

1M+24.9%

3M+42.7%

YTD-71.2%

1Y-82.0%

52-week range—

Beta0.32

Full chart and returns against a benchmark

Q-Score

22/ 100

Quality against peers; 50 is the peer median.

Growth—

Risk30

Performance15

Valuation42

Profitability—

Leverage48

Sentiment—

Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue—

Net income-$11.7M

Net margin—

Historical fundamentals

Red flags in filings

4active red flags

Going-concern doubtMar 31, 2026

Late filing noticeAug 17, 2026

Auditor changeNov 6, 2026

Filings, findings and the timeline

Valuation

SHPHIndustryP/E—35.25P/S—2.74EV/EBITDA—16.35P/B1.332.46PEG—0.87

Dividend yield0.00%

Every valuation metric

No reported financials for this company yet: it has too few SEC filings to chart.

Latest Results

The latest fiscal year and quarter, each against the same period a year earlier, from SEC filings.

Metric	FY 2025	vs a year before	Q2 2026	vs a year before
Net Income	-$11.7M	—	-$3.1M	—

Q-Scores

OverallCombines the categories below, except Sentiment

Industry 5922

Risk

Industry 6830

Performance

Industry 5915

Valuation

Industry 4942

Leverage

Industry 4448

Key Metrics

Fundamentals: trailing twelve months to Jun 2026, from the latest 10-K and 10-Qs.

Market Beta (5-factor)

IM 0.76SM 0.780.02

Market Cap

25.4M

Dividend Yield

IM 0.00%SM 0.00%0.00%

Volume

IM 1MSM 741.7K43K

Industry Market Share

0.01%

Sector Market Share

0.00%

IM industry median · SM sector median: the typical company the value is compared with. The /100 is its score against those peers.

Comparable Companies

The companies closest in size in Drug Manufacturers - Specialty & Generic (filled from its sector when there are few), with the median and rank across all 82 in the industry.

Company	Market cap	P/S	P/B	FCF yield	Implied growth	Revenue growth	Op. margin	ROE	Debt/equity
SHPHShuttle Pharmaceuticals Holdings, Inc.	$25.4M	—	1.3	-25.9%	—	—	—	-53.5%	0.0
IXHLIncannex Healthcare Inc.	$25.2M	—	0.4	-51.1%	—	—	—	-28.6%	0.0
CPHIChina Pharma Holdings, Inc.	$23.7M	6.1	0.7	-0.8%	—	-11.0%	-111.8%	-12.4%	0.0
RMTIRockwell Medical, Inc.	$29.5M	0.4	0.8	-4.1%	—	-31.8%	-6.8%	-14.4%	0.2
TXMDTherapeuticsMD, Inc.	$20.1M	6.2	0.7	15.4%	-19.1%	27.8%	-120.9%	-0.8%	0.0
AYTUAytu BioPharma, Inc.	$19.7M	0.3	0.6	16.5%	—	-13.3%	-14.4%	-40.4%	0.3
SCYXSCYNEXIS, Inc.	$35M	1.9	0.6	-34.4%	—	544.0%	-126.9%	-17.1%	0.0
INCRInterCure Ltd.	$46.7M	0.7	0.4	-41.8%	—	-33.4%	-28.1%	-18.3%	0.3
BFRIBiofrontera Inc.	$13.8M	0.3	2.3	-57.5%	—	17.8%	-14.2%	-106.9%	0.0
Industry median		1.9	1.7	0.1%	4.6%	8.9%	-7.1%	-14.9%	0.0
SHPH percentile		—	42nd	19th	—	—	—	24th	20th